Send the following on WhatsApp
Continue to ChatSécukinumab, Cosentyx*; anticorps anti-IL-17A https://www.pharmacorama.com/2016/10/secukinumab-cosentyx-anticorps-anti-il-17a/
Sécukinumab, Cosentyx*; anticorps anti-IL-17A https://www.pharmacorama.com/2016/10/secukinumab-cosentyx-anticorps-anti-il-17a/